Palvella Therapeutics PVLA
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts12
Average target$227.73+59.4% vs. price
- Buy 100%
Low $207.00Now $142.85Avg $227.73High $246.00
Recent rating changes
The last 20 actions on file set price targets from $207.00 to $266.00, averaging $232.78.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | CCORF | BUY | $243.00 |
| 6 Nov 2026 | Craig-Hallum | BUY | $230.00 |
| 6 Nov 2026 | Raymond James | BUY | $230.00 |
| 6 Nov 2026 | Truist Financial | BUY | $207.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $246.00 |
| 6 Nov 2026 | Oppenheimer | BUY | $232.00 |
| 5 Nov 2026 | BTIG | BUY | $215.00 |
| 29 Oct 2026 | Mizuho Securities | BUY | $232.00 |
| 28 Oct 2026 | William Blair | BUY | – |
| 21 Oct 2026 | Cantor Fitzgerald | BUY | $210.00 |
| 20 Oct 2026 | Clear Street | BUY | $220.00 |
| 20 Oct 2026 | H.C. Wainwright | BUY | $246.00 |
| 16 Oct 2026 | Raymond James | BUY | – |
| 15 Oct 2026 | William Blair | BUY | $266.00 |
| 12 Oct 2026 | BTIG | BUY | $215.00 |
| 12 Oct 2026 | H.C. Wainwright | BUY | $246.00 |
| 21 Sep 2026 | Chardan Capital | BUY | $240.00 |
| 10 Sep 2026 | Mizuho Securities | BUY | $240.00 |
| 31 Aug 2026 | Mizuho Securities | BUY | $240.00 |
| 5 Aug 2026 | CCORF | BUY | $232.00 |
No comments yet — be the first to weigh in on PVLA.
Sign in to join the discussion.